Antagonism of Coronavirus Spike Proteins by Cellular Host Factors

NIH Pandemic-Era Grants

Pandemic Era Grants

2020

Document text

Principal Investigator: eric  freed
Organization: DIVISION OF BASIC SCIENCES - NCI
Fiscal Year: 2020
Award: $232,377
Funding agency: National Cancer Institute

In a structural and functional analysis of the SARS-CoV-2 spike protein that we recently started, we have obtained preliminary data indicating that that MARCH8, but not a catalytically inactive MARCH8 mutant, targets the spike proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2 for degradation. We also determined that human airway epithelial cells express MARCH8 upon treatment with interferon. The work on MARCH protein-mediated antagonism may reveal new opportunities for therapeutic intervention with spike protein trafficking and incorporation into virus particles.

Terms: <2019 novel coronavirus><2019-nCoV><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Assay><Binding Proteins><Bioassay><Biologic Assays><Biological Assay><CoV S protein><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><Collaborations><Coronavirus glycoprotein S><Coronavirus spike protein><Cryo-electron tomography><Data><Development><E3 Ligase><E3 Ubiquitin Ligase><Ebola><Epithelial Cells><Family><Glycoproteins><Goals><HIV><Host Factor><Host Factor Protein><Human><Human Cell Line><Human Immunodeficiency Viruses><IFN><Immune response><Immunological response><Integration Host Factors><Interferons><LAV-HTLV-III><Ligand Binding Protein><Ligand Binding Protein Gene><Lymphadenopathy-Associated Virus><MERS corona virus><MERS coronavirus><MERS virus><MERS-CoV><Measures><Mediating><Middle East Respiratory Syndrome Corona Virus><Middle East Respiratory Syndrome Coronavirus><Middle East Respiratory Syndrome Virus><Middle East Respiratory Syndrome-CoV><Middle Eastern Respiratory Syndrome Corona virus><Middle Eastern Respiratory Syndrome Coronavirus><Middle Eastern Respiratory Syndrome Virus><Middle Eastern Respiratory Syndrome-CoV><Modern Man><NIEHS><National Institute of Environmental Health Sciences><Protein Analysis><Protein Binding><Protein Trafficking><Proteins><Research><SARS Virus><SARS corona virus><SARS coronavirus><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe acute respiratory syndrome coronavirus 2><Structure><Surface><Therapeutic Intervention><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><VSV><Vaccine Design><Vesicular Stomatitis Virus><Vesicular stomatitis Indiana virus><Viral><Virion><Virus><Virus Particle><Virus-HIV><Virus-like particle><Western Blotting><Western Immunoblotting><Work><Wuhan coronavirus><airway epithelium><bound protein><coronavirus S protein><coronavirus spike glycoprotein><cryo-EM tomography><cryoEM tomography><cryoelectron tomography><developmental><electron cryo-tomography><experiment><experimental research><experimental study><guanylate><host response><immunoresponse><inhibitor><inhibitor/antagonist><insight><intervention therapy><mutant><particle><protein blotting><protein function><protein transport><severe acute respiratory syndrome-CoV><trafficking><ubiquitin-protein ligase><vector><virus-like nanoparticles><viruslike particle>